Your browser doesn't support javascript.
loading
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth.
Doleschel, Dennis; Hoff, Sabine; Koletnik, Susanne; Rix, Anne; Zopf, Dieter; Kiessling, Fabian; Lederle, Wiltrud.
Afiliação
  • Doleschel D; Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Hoff S; Research and Development, Preclinical Research Oncology, Bayer AG, Berlin, Germany.
  • Koletnik S; Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Rix A; Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Zopf D; Research and Development, Preclinical Research Oncology, Bayer AG, Berlin, Germany. dieter.zopf@nuvisan.com.
  • Kiessling F; Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Lederle W; Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany.
J Exp Clin Cancer Res ; 40(1): 288, 2021 Sep 13.
Article em En | MEDLINE | ID: mdl-34517894
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias Colorretais / Receptor de Morte Celular Programada 1 / Imunoterapia Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias Colorretais / Receptor de Morte Celular Programada 1 / Imunoterapia Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha